{
    "id": 18331,
    "fullName": "ETV6 - FGFR3",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ETV6-FGFR3 results from the fusion of ETV6 (also referred to as TEL) and FGFR3 (PMID: 15514005), demonstrating constitutive kinase activity and the ability to transform cells in culture (PMID: 15514005).",
            "references": [
                {
                    "id": 4647,
                    "pubMedId": 15514005,
                    "title": "Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15514005"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2120,
        "geneSymbol": "ETV6",
        "terms": [
            "ETV6",
            "TEL",
            "TEL/ABL",
            "THC5"
        ]
    },
    "variant": "ETV6 - FGFR3",
    "createDate": "02/21/2016",
    "updateDate": "02/21/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 2261,
                "geneSymbol": "FGFR3",
                "terms": [
                    "FGFR3",
                    "ACH",
                    "CD333",
                    "CEK2",
                    "HSFGFR3EX",
                    "JTK4"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 10009,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with AZD4547 decreased Myc expression and inhibited growth of transformed cells expressing ETV6-FGFR3 (TEL-FGFR3) in culture (PMID: 27401245).",
            "molecularProfile": {
                "id": 18674,
                "profileName": "ETV6 - FGFR3"
            },
            "therapy": {
                "id": 654,
                "therapyName": "AZD4547",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7899,
                    "pubMedId": 27401245,
                    "title": "c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27401245"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18674,
            "profileName": "ETV6 - FGFR3",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}